$IBB call buyers post healthy gains
The iShares Nasdaq Biotechnology Index Fund (IBB) traded to a new all-time-high today, handing significant profits to upside option positions. On Apr. 1, Market Rebellion’s
The iShares Nasdaq Biotechnology Index Fund (IBB) traded to a new all-time-high today, handing significant profits to upside option positions. On Apr. 1, Market Rebellion’s
Option traders have run up huge gains on bullish contracts in Amgen (AMGN) that expire this week. On July 31, Our tracking systems showed that
Bullish option traders collected big profits in Amgen (AMGN) calls today. On July 31, Investitute’s proprietary programs flagged the purchase of 4,120 Weekly $190 calls,
Bullish option traders collected big profits in Amgen (AMGN) calls today. On July 23, Investitute’s proprietary programs flagged the purchase of 4,120 Weekly $182.50 calls,
Bullish option traders collected fast profits in Amgen today. Just yesterday, Investitute’s proprietary programs flagged the purchase of 4,800 May $172.50 calls for $0.15 to
Option call buyers banked a nice profit in Lowes(LOW) in 2 days. In our TNT Option trading service we covered how Lowes(LOW) stock price was
In our TNT Options Trading Service on January 14th, we talked about Amgen (AMGN). After watching the trend and the broader market, particularly the iShares
The iShares Nasdaq Biotechnology Index Fund traded lower today as its components fell, handing significant profits to downside option positions. On Thursday, Investitute’s proprietary programs flagged
AbbVie has rallied sharply in recent months, and option traders cashed in big on bullish positions today. On Sept. 21, Investitute’s market scanners identified the
Our services and education products provide information from Jon Najarian, Pete Najarian and our team of analysts and educators on trading options and securities as well as cryptocurrencies, tokens and coins (together “Digital Assets”). All investments involve risk, and the past performance of a security, Digital Asset, industry, sector, market, financial product, trading strategy, or individual’s trading does not guarantee future results or returns.
Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. Market Rebellion is not giving investment advice, tax advice, legal advice, or other professional advice.
Market Rebellion’s reference to specific securities or Digital Assets should not be construed as a recommendation to buy, sell or hold that security or Digital Asset. Specific securities or Digital Assets are mentioned for educational and informational purposes only.
©2023 Market Rebellion, LLC. All Rights Reserved.